Total Payments
$9,939
2024 Payments
$949.46
Companies
36
Transactions
511
Medicare Patients
2,453
Medicare Billing
$394,727
Payment Breakdown by Category
Food & Beverage$9,934 (99.9%)
Education$5.10 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,934 | 510 | 99.9% |
| Education | $5.10 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $1,826 | 97 | $0 (2024) |
| Biogen, Inc. | $1,490 | 72 | $0 (2024) |
| UCB, Inc. | $1,293 | 55 | $0 (2024) |
| Amgen Inc. | $784.40 | 43 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $745.05 | 47 | $0 (2024) |
| ABBVIE INC. | $613.17 | 30 | $0 (2024) |
| Lundbeck LLC | $338.34 | 17 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $297.13 | 16 | $0 (2023) |
| Amneal Pharmaceuticals LLC | $279.54 | 15 | $0 (2024) |
| Neurelis, Inc. | $264.08 | 14 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $949.46 | 40 | Novartis Pharmaceuticals Corporation ($140.20) |
| 2023 | $1,619 | 79 | UCB, Inc. ($314.74) |
| 2022 | $1,476 | 79 | Biogen, Inc. ($238.47) |
| 2021 | $1,997 | 104 | UCB, Inc. ($293.99) |
| 2020 | $1,811 | 96 | Teva Pharmaceuticals USA, Inc. ($654.65) |
| 2019 | $1,168 | 70 | Teva Pharmaceuticals USA, Inc. ($293.79) |
| 2018 | $491.27 | 25 | Amgen Inc. ($226.39) |
| 2017 | $427.09 | 18 | Teva Pharmaceuticals USA, Inc. ($219.46) |
All Payment Transactions
511 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $9.06 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Neurology | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Neurology | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Neurology | ||||||
| 07/11/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: PAIN | ||||||
| 07/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $117.52 | General |
| Category: PSYCHIATRY | ||||||
| 07/10/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $14.60 | General |
| 07/06/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: AMANTADINE | ||||||
| 07/06/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: AMANTADINE | ||||||
| 06/27/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: NEUROLOGY | ||||||
| 06/26/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: Adenosine A2A Receptors | ||||||
| 06/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Neurology | ||||||
| 06/10/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: AMANTADINE | ||||||
| 06/06/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $48.79 | General |
| Category: Neurology | ||||||
| 05/30/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Central Nervous System | ||||||
| 05/22/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Neurology | ||||||
| 05/15/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $31.63 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Neurology | ||||||
| 05/07/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: AMANTADINE | ||||||
| 05/07/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: AMANTADINE | ||||||
| 05/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: PSYCHIATRY | ||||||
| 05/01/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Neurology | ||||||
| 04/25/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.04 | General |
| Category: NEUROLOGY | ||||||
| 04/18/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $34.48 | General |
| Category: Neurology | ||||||
| 04/16/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $34.95 | General |
| Category: PAIN MANAGEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 562 | 913 | $195,115 | $94,154 |
| 2022 | 8 | 530 | 903 | $172,935 | $83,428 |
| 2021 | 8 | 672 | 1,150 | $324,738 | $115,124 |
| 2020 | 10 | 689 | 1,114 | $219,545 | $102,020 |
Total Patients
2,453
Total Services
4,080
Medicare Billing
$394,727
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 249 | 561 | $60,630 | $36,924 | 60.9% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 65 | 65 | $45,500 | $24,567 | 54.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 101 | 101 | $37,875 | $13,071 | 34.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 49 | 55 | $15,125 | $7,324 | 48.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 33 | 63 | $13,700 | $5,162 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 45 | $6,645 | $3,744 | 56.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 23 | 23 | $15,640 | $3,362 | 21.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 237 | 583 | $54,255 | $36,949 | 68.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 47 | 47 | $32,900 | $17,488 | 53.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 94 | 94 | $35,250 | $11,174 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 62 | 69 | $18,665 | $7,855 | 42.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 32 | 47 | $11,800 | $3,729 | 31.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 36 | $4,785 | $3,072 | 64.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 16 | 16 | $10,880 | $2,189 | 20.1% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2022 | 11 | 11 | $4,400 | $971.81 | 22.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 267 | 680 | $60,960 | $42,973 | 70.5% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2021 | 73 | 73 | $50,550 | $27,960 | 55.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 111 | 111 | $41,675 | $14,619 | 35.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 70 | 82 | $22,240 | $10,383 | 46.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 66 | 87 | $109,353 | $7,400 | 6.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 44 | 75 | $17,000 | $6,263 | 36.8% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 22 | 22 | $14,960 | $3,547 | 23.7% |
| 95908 | Nerve transmission studies, 3-4 studies | Office | 2021 | 19 | 20 | $8,000 | $1,980 | 24.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 231 | 568 | $51,540 | $32,296 | 62.7% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2020 | 65 | 66 | $45,590 | $24,056 | 52.8% |
About Dr. Thomas Eng, MD
Dr. Thomas Eng, MD is a Neurology healthcare provider based in Corona, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790858413.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Eng, MD has received a total of $9,939 in payments from pharmaceutical and medical device companies, with $949.46 received in 2024. These payments were reported across 511 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($9,934).
As a Medicare-enrolled provider, Eng has provided services to 2,453 Medicare beneficiaries, totaling 4,080 services with total Medicare billing of $394,727. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Specialist
- Location Corona, CA
- Active Since 11/17/2006
- Last Updated 03/18/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1790858413
Products in Payments
- AJOVY (Biological) $1,018
- Briviact (Drug) $983.65
- TYSABRI (Biological) $911.02
- Aimovig (Biological) $734.56
- KESIMPTA (Drug) $527.56
- UBRELVY (Drug) $452.51
- AJOVY (Drug) $330.09
- VYEPTI (Biological) $303.71
- RYTARY (Drug) $279.54
- VALTOCO (Drug) $264.08
- Soliris (Drug) $237.47
- COPAXONE (Drug) $219.46
- EMGALITY (Drug) $181.03
- REXULTI (Drug) $172.89
- VYVGART (Drug) $169.24
- Xeomin (Biological) $164.43
- AUBAGIO (Drug) $162.86
- APOKYN (Drug) $161.86
- TECFIDERA (Drug) $151.35
- VUMERITY (Drug) $147.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.